Here’s an interesting medical case where the flash of the camera saved the life of a young infant. A team of ophthalmic oncologists from the Memorial Sloan Kettering declared that a camera’s flash revealed cancer in a young child.
The story of the young child with eye cancer, by the name of Ryder Tamarantz, began in December. The 4-month old tyke was in good health according to Andrea Tamarantz, his mother. The woman was in the habit of taking lots of pictures of her child like all mothers do.
However, during the first set of photos, the child’s mother saw something resembling a white glow in Ryder’s left eye. Andrea dismissed the picture, saying that it could have been a camera glitch. However, several weeks later, Andrea shot another picture of Ryder, this time using a brand new Nikon camera. The white glow resurfaced again.
Being alarm by this new development, Andrea Tamarantz rushed young Ryder to the local hospital for a consultation. According to Ryder’s mother, the young infant was diagnosed with retinoblastoma on the 5th of January.
A retinoblastoma is a rare form of eye cancer that usually affects the light-detecting tissue found in the eye. This form of cancer usually occurs in the immature cells found in the eye, and it mainly affects young children.
The rate of survival after being diagnosed with this form of cancer is very high. Unfortunately, after being subjected to ophthalmic surgery for tumor removal, most children lose their eyes. According to recent research, retinoblastoma in young children can occur due to a genetic defect or to a congenital mutation.
A mother from Scottsdale declared that camera’s flash revealed cancer in a young child. After hearing about Ryder’s condition, Andrea did a little bit a research on the disease and found out that Ryder’s best change is the Memorial Sloan Kettering Hospital.
It would seem that the hospital has the largest staff in the world specialized in retinoblastoma. After consulting the young tyke, the doctors decided to subject young Ryder to a procedure called ophthalmic artery chemosurgery. Given Ryder’s age, the doctor said that the effects of chemo delivered this way will be minimal.
The doctors will introduce a small, thin tube in Ryder’s groin arteries. This tube will be carried by the bloodstream all the way up to the eye. The doctors will use this tube in order to deliver a precise quantity of chemo directly to the tumor.
Doctor David Abramson, who is the chief of the ophthalmic oncology wing, declared that the patient is responding well to the treatment and that he has a 99 percent chance of survival. Moreover, it would seem that if all goes well, Ryder will not lose vision in his left eye.